Journal profile · PHARMACOLOGY & PHARMACY
Bangladesh Journal of Pharmacology
ISSN 1991-007X · eISSN 1991-0088 · Bangladesh Pharmacological Society · BANGLADESH · Semiannual · Founded 2006
Bangladesh Journal of Pharmacology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.69; diamond open access (no APC); no APC; review over 12 weeks (community reports); community-reported acceptance: easy; 25 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Bangladesh Journal of Pharmacology is published by Bangladesh Pharmacological Society and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Natural Antidiabetic Agents Studies, Essential Oils and Antimicrobial Activity and Phytochemistry and Biological Activities, together about 32% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Bangladesh Journal of Pharmacology (Bangladesh J Pharmacol) is an open-access, video component, and peer-reviewed biomedical science journal of the Bangladesh Pharmacological Society (BDPS). Aims and Scope: The journal publishes papers on the studies of plant extracts or drugs on pharmacological effects, using laboratory animals, human cell lines, and microbes. The papers are Research Articles, Mini-reviews, Meta-analyses, Clinical Trials, Visual Experiments, and Letters to the Editor. Those who want to publish a research article must submit a video clip of one of the methodologies. Mini-reviews and Meta-analyses are usually unsolicited. A letter to the Editor is okay if the author(s) have data that is slightly different from published data. The studies on antihypertensive drugs, anti-HIV agents, molecular docking without the data from the wet lab, nanotechnology, and polyherbal products are not within the scope of this journal. The journal publishes four online issues (January, April, July, and October) per year. Journal MetricsJournal metrics allow you to compare journals, regardless of their subject classification.Impact Factor® as reported in the 2022 Journal Citation Reports®: 1.6 CiteScore (2021): 2.0 Current month's CiteScore TrackerH index (2023): 30 (It means 30 articles of this journal have more than 30 citations) Abstracted/Indexed inAcademic Search Complete, Bangladesh Journals Online, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Current Abstracts, Directory of Open Access Journals, EMBASE/Excerpta Medica, Global Health, Google Scholar, HINARI (WHO), International Pharmaceutical Abstracts, Open J-gate, Science Citation Index Expanded, SCOPUS and Social Sciences Citation Index MembersBangladesh Journal of Pharmacology is a member of OASPA (Open Access Scholarly Publishers Association), COPE (Committee on Publication Ethics), the International Society of Managing and Technical Editors (ISMTE) and the Asian Council of Science Editors.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Mir MisbahuddinPublisher website
Editorial board by country: 1 in mainland China (about 4%); most named Bangladesh 13, India 4, Pakistan 2, Mainland China 1, Iran 1 (23 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Natural Antidiabetic Agents StudiesMedicine12.5%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences10.5%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences8.9%
- Ethnobotanical and Medicinal Plants StudiesAgricultural and Biological Sciences6.3%
- Synthesis and biological activityChemistry6.1%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics5.8%
- Phytochemicals and Antioxidant ActivitiesMedicine5.5%
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SSCIEmbaseCAB AbstractsPublisher website
Other: Google Scholar, J-Gate, Academic Search Complete, Bangladesh Journals Online, Biological Abstracts, BIOSIS Previews, Current Abstracts, Global Health, HINARI (WHO), International Pharmaceutical Abstracts, Open J-gate
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.69LetPub ·
- Impact factor (publisher)
- 1.6Publisher website ·
- CiteScore 2026-06
- 1.3LetPub ·
- CiteScore (publisher) 2021
- 2Publisher website ·
- CiteScore (publisher) 2020
- 2.6Publisher website ·
- SJR 2026-06
- 0.17LetPub ·
- SJR (publisher) 2024
- 34Publisher website ·
- SNIP 2026-06
- 0.25LetPub ·
- h-index
- 19LetPub ·
- h-index
- 40OpenAlex ·
- i10-index
- 307OpenAlex ·
- 2-year mean citedness
- 0.45OpenAlex ·
- Self-citation rate
- 28.6%LetPub ·
- Share of gold OA articles
- 98%LetPub ·
Volume
- Articles per year
- 18LetPub ·
Articles by year OpenAlex count · 963 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 15 | 15 | 0 |
| 2025 | 25 | 25 | 10 |
| 2024 | 15 | 15 | 15 |
| 2023 | 23 | 23 | 35 |
| 2022 | 22 | 22 | 35 |
| 2021 | 18 | 18 | 62 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted6
- clinical trialsAuthors are invited to submit their Research Articles, Mini-Reviews, Meta-Analyses, Clinical Trials, Visual Experiments, and Letters to the Editor.Length not stated
- letters to the editorAuthors are invited to submit their Research Articles, Mini-Reviews, Meta-Analyses, Clinical Trials, Visual Experiments, and Letters to the Editor.Length not stated
- meta-analysesAuthors are invited to submit their Research Articles, Mini-Reviews, Meta-Analyses, Clinical Trials, Visual Experiments, and Letters to the Editor.Length not stated
- mini-reviewsAuthors are invited to submit their Research Articles, Mini-Reviews, Meta-Analyses, Clinical Trials, Visual Experiments, and Letters to the Editor.Length not stated
- research articlesAuthors are invited to submit their Research Articles, Mini-Reviews, Meta-Analyses, Clinical Trials, Visual Experiments, and Letters to the Editor.Length not stated
- visual experimentsAuthors are invited to submit their Research Articles, Mini-Reviews, Meta-Analyses, Clinical Trials, Visual Experiments, and Letters to the Editor.Length not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access
Open access, peer-reviewed biomedical science journal published by the Bangladesh Pharmacological Society (BDPS). Model summary
The Bangladesh Journal of Pharmacology (Bangladesh J Pharmacol) is an open-access, peer-reviewed biomedical science journal published by the Bangladesh Pharmacological Society (BDPS).
Source ↗Publisher website ·- Peer review
Includes video components and publishes four online issues annually—in January, April, July, and October. Model summary
It includes video components and publishes four online issues annually—in January, April, July, and October.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Bangladesh Pharmacological Society
- Country or region
- BANGLADESH
- Language
- English
- Frequency
- Semiannual
- Founded
- 2006
- ISSN
- 1991-007X
- Electronic ISSN
- 1991-0088
- Latest issue on the website
- Volume 21, Issue 3 (2026)
- Official links
FAQ
Frequently asked questions about Bangladesh Journal of Pharmacology
What CAS zone is Bangladesh Journal of Pharmacology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Bangladesh Journal of Pharmacology is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Bangladesh Journal of Pharmacology?
The latest impact factor listed by LetPub is 0.69; CiteScore 1.3, h-index 40.
How long does peer review take at Bangladesh Journal of Pharmacology?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Bangladesh Journal of Pharmacology based?
Of the 23 board members whose country the journal's board page names, 1 (about 4%) are in mainland China; the countries named most often are Bangladesh (13), India (4) and Pakistan (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Bangladesh Journal of Pharmacology?
According to LetPub and DOAJ records, Bangladesh Journal of Pharmacology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists SSCI, Embase and CAB Abstracts; that list has not been checked against each database.
Is Bangladesh Journal of Pharmacology open access, and what is the APC?
Bangladesh Journal of Pharmacology is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .